Susanne Churchill

Susanne Churchill, PhD

Executive Director, DBMI, Harvard Medical School
Instructor in Medicine, Brigham and Women's Hospital

10 Shattuck St Boston MA 02115

Susanne Churchill received her PhD from Boston University School of Medicine and did her postdoctoral training at Harvard Medical School in the field of cardiovascular and renal physiology, progressing to instructor and lecturer. She co-founded the Institute for Circadian Physiology in Boston, where she served as chief operating officer while continuing her research in space medicine and teaching. She returned full time to HMS to serve as director of sponsored programs administration and subsequently was appointed associate dean for research. Churchill next joined forces with Isaac Kohane to lead the successful Informatics for Integrating Biology and the Bedside (i2b2) National Center for Biomedical Computing at Partners HealthCare as its executive director and principle investigator of the educational core. She joined DBMI in 2015 as executive director of the department, executive director of the Big Data to Knowledge (BD2K) Center of Excellence, executive director of the N-GRID (neuropsychiatric genome-scale and RDoC-Individualized domains) Center of Excellence in Genome Science and program director for the long-running Summer Institute in Biomedical Informatics (SIBMI). Churchill is also an instructor in the Channing Division of Network Medicine at Brigham and Women’s Hospital.

Carbon monoxide poisoning in Utah: 1996-2013.
Authors: Weaver LK, Deru K, Churchill S, Legler J, Snow G, Grey T.
Undersea Hyperb Med
View full abstract on Pubmed
Rates of visual acuity change in patients receiving hyperbaric oxygen in monoplace and multiplace chambers.
Authors: Churchill S, Deru K, Wilson G, Cable R, Bell JE, Weaver LK.
Undersea Hyperb Med
View full abstract on Pubmed
Persuading People to Drink Less Alcohol: The Role of Message Framing, Temporal Focus and Autonomy.
Authors: Churchill S, Pavey L, Jessop D, Sparks P.
Alcohol Alcohol
View full abstract on Pubmed
Statin Use Is Associated With Reduced Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases.
Authors: Ananthakrishnan AN, Cagan A, Cai T, Gainer VS, Shaw SY, Churchill S, Karlson EW, Murphy SN, Liao KP, Kohane I.
Clin Gastroenterol Hepatol
View full abstract on Pubmed
Comparative Effectiveness of Infliximab and Adalimumab in Crohn's Disease and Ulcerative Colitis.
Authors: Ananthakrishnan AN, Cagan A, Cai T, Gainer VS, Shaw SY, Savova G, Churchill S, Karlson EW, Kohane I, Liao KP, Murphy SN.
Inflamm Bowel Dis
View full abstract on Pubmed
Absence of evidence for increase in risk for autism or attention-deficit hyperactivity disorder following antidepressant exposure during pregnancy: a replication study.
Authors: Castro VM, Kong SW, Clements CC, Brady R, Kaimal AJ, Doyle AE, Robinson EB, Churchill SE, Kohane IS, Perlis RH.
Transl Psychiatry
View full abstract on Pubmed
Identification of Nonresponse to Treatment Using Narrative Data in an Electronic Health Record Inflammatory Bowel Disease Cohort.
Authors: Ananthakrishnan AN, Cagan A, Cai T, Gainer VS, Shaw SY, Savova G, Churchill S, Karlson EW, Murphy SN, Liao KP, Kohane I.
Inflamm Bowel Dis
View full abstract on Pubmed
Common Genetic Variants Influence Circulating Vitamin D Levels in Inflammatory Bowel Diseases.
Authors: Ananthakrishnan AN, Cagan A, Cai T, Gainer VS, Shaw SY, Churchill S, Karlson EW, Murphy SN, Kohane I, Liao KP, Xavier RJ.
Inflamm Bowel Dis
View full abstract on Pubmed
Toward high-throughput phenotyping: unbiased automated feature extraction and selection from knowledge sources.
Authors: Yu S, Liao KP, Shaw SY, Gainer VS, Churchill SE, Szolovits P, Murphy SN, Kohane IS, Cai T.
J Am Med Inform Assoc
View full abstract on Pubmed
Diabetes and the risk of infections with immunomodulator therapy in inflammatory bowel diseases.
Authors: Ananthakrishnan AN, Cagan A, Cai T, Gainer VS, Shaw SY, Churchill S, Karlson EW, Murphy SN, Kohane I, Liao KP.
Aliment Pharmacol Ther
View full abstract on Pubmed